4-Methylpyridine-3-carbaldehyde → [1-((R)-3-amino-1-methyl-propyl)-piperidin-4-yl]-[4-(tert-butyl-dimethyl-silanyloxy)-phenyl]-(4-methyl-pyridin-3-ylmethyl)-amine
反応式
C(OC(=O)[NH:7][CH2:8][CH2:9][C@H:10]([N:12]1[CH2:17][CH2:16][CH:15]([NH:18][C:19]2[CH:24]=[CH:23][C:22]([O:25][Si:26]([C:29]([CH3:32])([CH3:31])[CH3:30])([CH3:28])[CH3:27])=[CH:21][CH:20]=2)[CH2:14][CH2:13]1)[CH3:11])(C)(C)C.[CH3:34][C:35]1[CH:40]=[CH:39][N:38]=[CH:37][C:36]=1[CH:41]=O>C(Cl)CCl>[NH2:7][CH2:8][CH2:9][C@H:10]([N:12]1[CH2:13][CH2:14][CH:15]([N:18]([C:19]2[CH:20]=[CH:21][C:22]([O:25][Si:26]([C:29]([CH3:30])([CH3:32])[CH3:31])([CH3:27])[CH3:28])=[CH:23][CH:24]=2)[CH2:41][C:36]2[CH:37]=[N:38][CH:39]=[CH:40][C:35]=2[CH3:34])[CH2:16][CH2:17]1)[CH3:11]参加物
4
反応物 2
生成物 1
試薬・触媒・溶媒 1
実験手順
Using general procedure A with ((R)-3-{4-[4-(tert-butyl-dimethyl-silanyloxy)-phenylamino]-piperidin-1-yl}-butyl)-carbamic acid tert-butyl ester (see EXAMPLE 233) (796 mg, 2.10 mmol) and 4-methyl-3-pyridinecarboxaldehyde (see EXAMPLE 356) (367 mg, 3.00 mmol) in ClCH2CH2Cl (6 mL) followed by general procedure C afforded [1-((R)-3-amino-1-methyl-propyl)-piperidin-4-yl]-[4-(tert-butyl-dimethyl-silanyloxy)-phenyl]-(4-methyl-pyridin-3-ylmethyl)-amine (130 mg, 17% over 2 steps) as a white foam.
出典と根拠
- ORDレコード
- ord-7e192d42ea43462e8ef294a0ec52e501
- 出典データセット
- uspto-grants-2009_02
- 特許番号
- US07491735B2
反応ノート
読み込み中…